stella
beta
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer — Stella
Recruiting
Back to Breast Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
China
Xijing Hospital Affiliated to Air Force Military Medical University, Xi'an, Shannxi Province
Xijing Hospital Affiliated to Air Force Military Medical University, Xi'an, Shannxi
View full record on ClinicalTrials.gov